z-logo
Premium
Marine Hydroquinone Zonarol Prevents Inflammation and Apoptosis in Dextran Sulfate Sodium‐Induced Mice Ulcerative Colitis
Author(s) -
Yamada Sohsuke,
Koyama Tomoyuki,
Noguchi Hirotsugu,
Nawata Aya,
Nakayama Toshiyuki,
Satoh Takumi
Publication year - 2015
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.29.1_supplement.766.5
Subject(s) - sulfasalazine , colitis , ulcerative colitis , inflammatory bowel disease , pharmacology , inflammation , apoptosis , medicine , immune system , immunology , chemistry , disease , biochemistry
We identified an anti‐inflammatory compound, zonarol, isolated from the brown algae as a marine natural product. To ascertain the in vivo functions of zonarol, we examined the pharmacological effects of zonarol administration on dextran sulfate sodium (DSS)‐induced inflammation in a mouse model of ulcerative colitis (UC). Our goal is to establish a safe and effective cure for inflammatory bowel disease (IBD) using zonarol. We subjected Slc:ICR mice to the administration of 2% DSS in drinking water for 14 days. At the same time, 5‐aminosalicylic acid (5‐ASA) at a dose of 50 mg/kg and zonarol at doses of 10 and 20 mg/kg, were given orally once a day. DSS‐treated animals developed symptoms similar to those of human UC, such as severe bloody diarrhea, which were evaluated by the disease activity index (DAI). Treatment with 20 mg/kg of zonarol, as well as 5‐ASA, significantly suppressed the DAI score, and also led to a reduced colonic ulcer length and/or mucosal inflammatory infiltration by various immune cells, especially macrophages. Zonarol treatment significantly reduced the expression of pro‐inflammatory signaling molecules, and prevented the apoptosis of intestinal epithelial cells. A marine bioproduct protects against experimental UC via the inhibition of both inflammation and apoptosis, very similar to the standard‐of‐care sulfasalazine, a well‐known prodrug that releases 5‐ASA.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom